Plain-English translation of NCT03830151 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new imaging method called hyperpolarized carbon C-13 pyruvate imaging to help doctors better diagnose and understand brain tumors. You would receive an injection of the special dye and then have an advanced brain scan. The goal is to see if this new imaging technique can provide better information about your tumor than standard scans alone.
Doctors currently use standard MRI scans to look at brain tumors, but these scans don't always show all the important details about how aggressive a tumor is or how it will behave. This trial is testing whether the new imaging technique can provide extra information to help doctors understand tumors better and plan the best treatment.
You likely qualify if…
You likely don't qualify if…
You would visit M.D. Anderson Cancer Center for this study. First, you would have a standard MRI scan with special imaging sequences (done within 14 days before your procedure, ideally within 3 days). Then, at your main study visit, you would receive a quick injection of the special dye into your vein over about 10–20 seconds, followed immediately by an advanced brain scan. After the scan is complete, you would have one follow-up check the next day. The entire process is designed to fit around your planned brain tumor surgery.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States